Ben Osborn, a British executive at pharmaceutical company Pfizer, criticized the proposal to get the pharmaceutical company to give up COVID-19 's vaccine patent, warning that it could lead to a global shortage of raw materials, the Sunday Times reported.
Abandoning intellectual property "is not the solution," Osborn said. This could allow any institution to start purchasing the most basic raw materials in many countries. (end)
-- Source:
Note: Reuters did not verify the above information and does not guarantee its correctness. (end)
* if you want to refer to the original report, please click and browse *
(compiled by Li Chunxi, revised by Zhang Ruoqi)
((chunxi.li@thomsonreuters.com; 86-10-56692087;)
Abandoning intellectual property "is not the solution," Osborn said. This could allow any institution to start purchasing the most basic raw materials in many countries. (end)
-- Source:
Note: Reuters did not verify the above information and does not guarantee its correctness. (end)
* if you want to refer to the original report, please click and browse *
(compiled by Li Chunxi, revised by Zhang Ruoqi)
((chunxi.li@thomsonreuters.com; 86-10-56692087;)